Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126174122 | 12617412 | 2 | F | 2013 | 20160816 | 20160803 | 20160930 | PER | US-ASTRAZENECA-2016SE45277 | ASTRAZENECA | 56.00 | YR | F | Y | 76.20000 | KG | 20160930 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126174122 | 12617412 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400MCG 1 PUFF TWICE DAILY | 202450 | INHALATION POWDER | |||||||||
| 126174122 | 12617412 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400MCG 1 PUFF TWICE DAILY | 202450 | INHALATION POWDER | |||||||||
| 126174122 | 12617412 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 126174122 | 12617412 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
| 126174122 | 12617412 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | GENERIC | U | 0 | |||||||||
| 126174122 | 12617412 | 6 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 8 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 9 | C | MOMETASONE FUROATE. | MOMETASONE FUROATE | 1 | Nasal | 0 | |||||||||||
| 126174122 | 12617412 | 10 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 0 | |||||||||||
| 126174122 | 12617412 | 11 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 0 | |||||||||||
| 126174122 | 12617412 | 12 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 126174122 | 12617412 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | AT NIGHT | 0 | |||||||||||
| 126174122 | 12617412 | 14 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | INTERMITTENT,AS NEEDED | 0 | ||||||||||
| 126174122 | 12617412 | 15 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 16 | C | ADVIL | IBUPROFEN | 1 | INTERMITTENT | 0 | |||||||||||
| 126174122 | 12617412 | 17 | C | ALEVE | NAPROXEN SODIUM | 1 | INTERMITTENT | 0 | |||||||||||
| 126174122 | 12617412 | 18 | C | CELEBREX | CELECOXIB | 1 | AT NIGHT | 0 | |||||||||||
| 126174122 | 12617412 | 19 | C | CLARITIN | LORATADINE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 20 | C | LORATADINE. | LORATADINE | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 21 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | ||||||||||||
| 126174122 | 12617412 | 22 | C | CLONAZEPAM. | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126174122 | 12617412 | 1 | Asthma |
| 126174122 | 12617412 | 2 | Chronic obstructive pulmonary disease |
| 126174122 | 12617412 | 6 | Dyspnoea |
| 126174122 | 12617412 | 7 | Sinus disorder |
| 126174122 | 12617412 | 8 | Upper-airway cough syndrome |
| 126174122 | 12617412 | 9 | Multiple allergies |
| 126174122 | 12617412 | 10 | Multiple allergies |
| 126174122 | 12617412 | 11 | Multiple allergies |
| 126174122 | 12617412 | 16 | Arthralgia |
| 126174122 | 12617412 | 17 | Arthralgia |
| 126174122 | 12617412 | 18 | Arthralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126174122 | 12617412 | Anxiety | |
| 126174122 | 12617412 | Arthralgia | |
| 126174122 | 12617412 | Arthritis | |
| 126174122 | 12617412 | Asthma | |
| 126174122 | 12617412 | Chronic obstructive pulmonary disease | |
| 126174122 | 12617412 | Dry throat | |
| 126174122 | 12617412 | Dysphonia | |
| 126174122 | 12617412 | Frustration tolerance decreased | |
| 126174122 | 12617412 | Gastrooesophageal reflux disease | |
| 126174122 | 12617412 | Hypersensitivity | |
| 126174122 | 12617412 | Irritability | |
| 126174122 | 12617412 | Nocturnal dyspnoea | |
| 126174122 | 12617412 | Product quality issue | |
| 126174122 | 12617412 | Upper-airway cough syndrome | |
| 126174122 | 12617412 | Weight increased | |
| 126174122 | 12617412 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126174122 | 12617412 | 1 | 20160415 | 0 | ||
| 126174122 | 12617412 | 2 | 20160415 | 0 | ||
| 126174122 | 12617412 | 9 | 201603 | 0 | ||
| 126174122 | 12617412 | 10 | 201603 | 0 | ||
| 126174122 | 12617412 | 12 | 20160415 | 0 | ||
| 126174122 | 12617412 | 19 | 2014 | 0 | ||
| 126174122 | 12617412 | 20 | 2014 | 0 |